UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)
CUSIP: 917488108
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 3,203,885
- Total 13F shares
- 2,166,272
- Share change
- +7,279
- Total reported value
- $136,441,085
- Price per share
- $62.97
- Number of holders
- 115
- Value change
- +$654,850
- Number of buys
- 50
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 917488108?
CUSIP 917488108 identifies UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 917488108:
Top shareholders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP |
13D/G
13F
|
Company |
10%
|
333,204
|
$18,559,463 | +$3,434,852 | 31 Aug 2025 | |
| Kevin L. Cornwell |
3/4/5
|
Chairman, CEO, Secretary, Director |
—
class O/S missing
|
188,472
|
$17,774,794 | — | 22 Nov 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
13D/G
|
Company |
6.7%
from 13D/G
|
213,314
|
$12,141,833 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
197,466
|
$11,240,069 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.3%
from 13D/G
|
179,509
|
$10,217,677 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
177,097
|
$10,080,361 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.6%
|
114,816
|
$6,536,520 | — | 30 Jun 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.5%
|
111,950
|
$6,372,194 | — | 30 Jun 2025 | |
| Minerva Advisors LLC |
13F
|
Company |
2.9%
|
93,058
|
$5,267,083 | — | 30 Jun 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
2.7%
|
92,360
|
$4,848,900 | $0 | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
70,122
|
$4,011,884 | — | 30 Jun 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
2.1%
|
68,223
|
$3,883,253 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
58,156
|
$3,310,282 | — | 30 Jun 2025 | |
| Huber Capital Management LLC |
13F
|
Company |
1.7%
|
55,348
|
$3,150,408 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
49,136
|
$2,796,819 | — | 30 Jun 2025 | |
| ISTHMUS PARTNERS, LLC |
13F
|
Company |
1.1%
|
33,795
|
$1,923,611 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
33,440
|
$1,903,405 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.94%
|
29,980
|
$1,706,462 | — | 30 Jun 2025 | |
| Cardinal Capital Management |
13F
|
Company |
0.71%
|
22,780
|
$1,303,502 | — | 30 Jun 2025 | |
| Paul O Richins |
3/4/5
|
Director |
0.66%
|
21,136
|
$1,275,346 | — | 25 Aug 2025 | |
| BARD ASSOCIATES INC |
13F
|
Company |
0.62%
|
20,007
|
$1,144,704 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.56%
|
17,800
|
$1,013,176 | — | 30 Jun 2025 | |
| EVERETT HARRIS & CO /CA/ |
13F
|
Company |
0.55%
|
17,478
|
$994,848 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.5%
|
16,118
|
$918,000 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.49%
|
15,800
|
$899,336 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.43%
|
13,708
|
$780,259 | — | 30 Jun 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.4%
|
12,974
|
$738,000 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.39%
|
12,540
|
$713,777 | — | 30 Jun 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
11,685
|
$665,110 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.35%
|
11,221
|
$638,699 | — | 30 Jun 2025 | |
| Quantinno Capital Management LP |
13F
|
Company |
0.33%
|
10,690
|
$608,475 | — | 30 Jun 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.3%
|
9,744
|
$554,649 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.29%
|
9,367
|
$533,170 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.29%
|
9,287
|
$528,616 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.27%
|
8,755
|
$498,335 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
8,620
|
$490,651 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.27%
|
8,532
|
$485,694 | — | 30 Jun 2025 | |
| Ernst G. Hoyer |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$471,550 | — | 23 Nov 2021 | |
| Barbara A. Payne |
3/4/5
|
Director |
—
class O/S missing
|
4,838
|
$456,272 | — | 08 Feb 2023 | |
| Atria Investments, Inc |
13F
|
Company |
0.2%
|
6,403
|
$364,459 | — | 30 Jun 2025 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.2%
|
6,336
|
$360,645 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.19%
|
6,234
|
$355,000 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.19%
|
6,153
|
$350,229 | — | 30 Jun 2025 | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
5,890
|
$335,259 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.18%
|
5,716
|
$325,349 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.18%
|
5,669
|
$322,679 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
5,483
|
$312,092 | — | 30 Jun 2025 | |
| SEIZERT CAPITAL PARTNERS, LLC |
13F
|
Company |
0.17%
|
5,436
|
$309,417 | — | 30 Jun 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.17%
|
5,382
|
$306,343 | — | 30 Jun 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.17%
|
5,328
|
$303,270 | — | 30 Jun 2025 |
Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) as of Q3 2025
As of 30 Sep 2025,
UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,166,272 shares.
The largest 10 holders included
BRANDES INVESTMENT PARTNERS, LP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Minerva Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and RICE HALL JAMES & ASSOCIATES, LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
109
Q3 2025 holders
115
Holder diff
6
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.